Introduction: Mass screening, health technology assessment, and health policy in some European countries
article
Objective: The series of papers in this issue was developed to examine the use of health technology assessment in policies toward prevention - specifically toward mass screening - in European countries. The papers actually examined three screening strategies: mammography screening for breast cancer, prostate-specific antigen screening for prostate cancer, and routine ultrasound in normal pregnancy. Methods: Papers were sought from the member states of the European Union, plus Switzerland. Ultimately, nine acceptable papers were received, and were reviewed, revised, and edited. Results: Screening is an accepted strategy in many countries for reducing the burden of disease through early detection and intervention. In part, this is because of successful screening programs that have been evaluated and implemented in many countries. At the same time, unevaluated and even useless and harmful screening programs - unjustified medically or economically - are widespread. Health technology assessment could help assure that only effective and cost-effective screening programs are implemented. Conclusion: The main conclusion is that screening is an important preventive strategy. Any screening program, however, should be carefully assessed before implementation.
Topics
Health policyHealth technology assessmentScreeningprostate specific antigenbiomedical technology assessmentbreast cancercost effectiveness analysishealth care policyhealth programmammographymass screeningpregnancyprimary preventionprostate cancerreviewultrasoundCost-Benefit AnalysisEuropeHumansMass ScreeningTechnology Assessment, Biomedical
TNO Identifier
280352
ISSN
02664623
Source
International Journal of Technology Assessment in Health Care, 17(3), pp. 269-274.
Pages
269-274
Files
To receive the publication files, please send an e-mail request to TNO Repository.